Detalhe da pesquisa
1.
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.
BMC Cancer
; 20(1): 333, 2020 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32306920